Understanding Factors Behind ADP's Guidance Change in Q3 2026 Earnings

Ecolab growth drivers for High Tech and Life Sciences in 2026 (from the 2026 Q1 earnings transcript)

1) Global High Tech (High Tech & Digital): growth is being driven by AI-led demand for data-center and circular water/cooling solutions, plus CoolIT scaling and integration across OVIVO + Ecolab water business

• Strong organic growth trend in 2026: Global High Tech and Digital “grew more than 20%” in the quarter, indicating strong momentum going into 2026. ¹
• AI-driven demand for circular water management and high-performance cooling: Management explicitly ties the >20% growth to “strong demand tied to digital adoption and the ongoing AI wave,” and further notes “AI is driving significant new demand for circular water management and high-performance cooling.” ¹²
• CoolIT (acquired / pending) adds incremental high-tech growth momentum: CoolIT is described as starting “well ahead of the 30%+” sales growth discussed on the acquisition call, with “first quarter sales growing well ahead” of that threshold. ³
• The growth impact from CoolIT and integration into Global High Tech: Ecolab frames the combination of CoolIT + OVIVO + its Global High Tech water business as building a “$1.5 billion powerhouse” intended to “fuel Ecolab Inc.’s next phase of growth and margin expansion,” with the combined platform supporting customers’ uptime/cooling/water management needs as AI infrastructure scales. ²
• Customer-specific technology outcomes that pull demand forward: Ecolab states that as compute power increases with lower energy use, customers prioritize “uptime, cooling performance, and reliable water management,” and Ecolab’s circular water solutions are described across ultra-pure water to “direct-to-chip cooling.” ²
• OVIVO’s role and cross-sell logic (water circularity to chip yields): Ecolab highlights OVIVO’s ultra-pure water as impacting “the yield of the chips manufactured,” while also reducing net water usage “by 95%,” which creates a direct performance/relevance reason for adoption in microelectronics. ⁴
• Cooling system recurrency supports sustained spend: The transcript characterizes the technology/product cycle as inherently recurring: as chip generations change, customers change “systems for direct-to-chip cooling,” including “new cold plates, new coolant,” and “CDUs,” implying ongoing service/product demand rather than one-off projects. ⁵

Bottom line for High Tech in 2026: The central 2026 growth drivers are AI/digital infrastructure demand for cooling + circular water, and incremental acceleration from CoolIT, all reinforced by technology outcomes (uptime and direct-to-chip cooling) and recurring installation/service cycles. ¹³²⁴⁵

---

2) Life Sciences: growth is being driven by bioprocessing expansion, double-digit momentum, and capacity/capability investments leading to higher operating leverage potential

• Life Sciences is accelerating into double-digit growth in 2026: Life Sciences “accelerated to 11% growth” in the quarter, establishing a baseline of strong performance early in 2026. ¹
• Primary growth engine is bioprocessing, where sales “more than doubled”: Management states Life Sciences growth is “led by bioprocessing, where sales more than doubled.” ¹
• Investments in talent, capabilities, capacity, and innovation are explicitly linked to results: Management attributes the performance to “investing in talent, capabilities, capacity, and breakthrough innovation” and says these efforts are “clearly paying off.” ¹
• Near-term expectation: continued double-digit growth and margin expansion toward a 30% operating margin target: Ecolab expects Life Sciences’ growth to “continue its double-digit momentum” and operating income margin to expand “toward our 30% target over the next few years.” ¹
• Short-to-mid-term operating leverage is expected to continue improving as capacity comes online: Management indicates that to keep investing and expanding capacity (e.g., “a plant that we are going to open in the second half of the year”), they may be “in the mid-20s” on margin in the near/mid term, with confidence that they will reach 30% as investment impacts play out. ⁶
• Capacity is a gating factor being actively solved: In the discussion of growth dynamics, management emphasizes needing “more capacity—a good problem to have” due to customer demand pulling services beyond prior expectations. ⁷
• 2026 positioning: the business is built to sustain fast growth: Management characterizes Life Sciences as “the fastest-growing business in the Life Sciences industry right now” and expects it to “stay that way.” ⁶

Bottom line for Life Sciences in 2026: Growth drivers are bioprocessing outperformance (sales more than doubled), capacity/capability build-out that enables sustained double-digit growth (11% already), and a trajectory toward higher operating margins as investments and new capacity come online. ¹⁷⁶

---

Combined takeaway: what is most responsible for 2026 growth in both segments?

Ecolab frames both High Tech and Life Sciences as “two amazing growth engines” focused on growth industries that are also positioned with “very little dependent on any energy impact.” ⁸ In 2026 specifically, the transcript’s narrative is:

• High Tech: AI/digital adoption creates a step-up in demand for cooling + circular water management, with CoolIT scaling above expectations and platform integration (CoolIT + OVIVO + Ecolab water) reinforcing growth. ¹³²
• Life Sciences: bioprocessing-led momentum (sales more than doubled) is being converted into sustainable double-digit growth through investments and capacity expansion, supporting both growth and margin improvement. ¹⁶

This is the reported driver set for 2026 growth in the two segments covered. ¹³²⁸⁴⁶